News Image

EXELIXIS INC (NASDAQ:EXEL) qualifies as a high growth stock and is consolidating.

By Mill Chart

Last update: Apr 14, 2025

Exploring Growth Potential: EXELIXIS INC (NASDAQ:EXEL) and Its Base Formation. Growth investors seek promising revenue and EPS growth, and EXELIXIS INC has come under our scrutiny for potential growth investing. While it's crucial to do your own research, we've detected EXELIXIS INC on our screen for growth with base formation, suggesting it merits a closer look.


High Growth setup stocks image

A Closer Look at Growth for EXEL

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. EXEL has received a 8 out of 10:

  • The Earnings Per Share has grown by an impressive 189.06% over the past year.
  • EXEL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.65% yearly.
  • EXEL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.50%.
  • EXEL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.51% yearly.
  • The Earnings Per Share is expected to grow by 26.65% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 10.95% on average over the next years. This is quite good.
  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

A Closer Look at Health for EXEL

Every stock is evaluated by ChartMill, receiving a Health Rating on a scale of 0 to 10. This assessment considers different health aspects, including liquidity and solvency, both in absolute terms and relative to industry peers. EXEL has achieved a 9 out of 10:

  • EXEL has an Altman-Z score of 10.32. This indicates that EXEL is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of EXEL (10.32) is better than 90.14% of its industry peers.
  • There is no outstanding debt for EXEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
  • EXEL has a Current Ratio of 3.63. This indicates that EXEL is financially healthy and has no problem in meeting its short term obligations.
  • EXEL has a Quick Ratio of 3.58. This indicates that EXEL is financially healthy and has no problem in meeting its short term obligations.

A Closer Look at Profitability for EXEL

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For EXEL, the assigned 8 is a significant indicator of profitability:

  • The Return On Assets of EXEL (17.68%) is better than 97.89% of its industry peers.
  • EXEL has a Return On Equity of 23.23%. This is amongst the best in the industry. EXEL outperforms 97.89% of its industry peers.
  • The Return On Invested Capital of EXEL (21.31%) is better than 98.77% of its industry peers.
  • The last Return On Invested Capital (21.31%) for EXEL is above the 3 year average (10.78%), which is a sign of increasing profitability.
  • The Profit Margin of EXEL (24.04%) is better than 97.18% of its industry peers.
  • Looking at the Operating Margin, with a value of 31.81%, EXEL belongs to the top of the industry, outperforming 98.42% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 96.49%, EXEL belongs to the top of the industry, outperforming 95.25% of the companies in the same industry.

How does the Setup look for EXEL

ChartMill provides a Setup Rating for each stock. This rating, ranging from 0 to 10, assesses the level of consolidation in the stock based on multiple short-term technical indicators. Currently, EXEL has a 8 as its setup rating, indicating its current consolidation status.

Although the technical rating is only medium, EXEL does present a nice setup opportunity. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 35.57. Right above this resistance zone may be a good entry point.

More Strong Growth stocks can be found in our Strong Growth screener.

Check the latest full fundamental report of EXEL for a complete fundamental analysis.

Our latest full technical report of EXEL contains the most current technical analsysis.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

EXELIXIS INC

NASDAQ:EXEL (5/22/2025, 4:15:18 PM)

After market: 43.25 +0.39 (+0.91%)

42.86

-0.86 (-1.97%)



Find more stocks in the Stock Screener

EXEL Latest News and Analysis

ChartMill News Image10 hours ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) – A Strong Growth Stock with Attractive Valuation

EXELIXIS INC (NASDAQ:EXEL) offers strong growth, solid profitability, and an attractive valuation, making it a compelling choice for investors seeking affordable growth stocks in the biotech sector.

ChartMill News Image2 days ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) – An Undervalued Biotech Stock with Strong Fundamentals

EXELIXIS INC (NASDAQ:EXEL) is an undervalued biotech stock with strong profitability, financial health, and growth potential, making it a candidate for value investors.

ChartMill News Image5 days ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) – A Strong Contender in High Growth Momentum and Minervini’s Trend Template

EXELIXIS INC (NASDAQ:EXEL) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a standout in biotech. Review its full technical and fundamental strengths before considering an investment.

Follow ChartMill for more